Source link : https://www.newshealth.biz/health-news/tricuspid-valve-replacement-finds-surer-footing-with-triscend-iis-1-year-report/
The Evoque transcatheter tricuspid valve replacement (TTVR) system continued to show significant benefits 1 year after implant, according to an update from the TRISCEND II trial. Among study participants with symptomatic, severe tricuspid regurgitation (TR), those randomized to TTVR, in lieu of medical therapy alone, had significantly better 1-year outcomes per win ratio analysis on […]
Author : News Health
Publish date : 2024-10-31 15:18:41
Copyright for syndicated content belongs to the linked Source.
inHealth